Syqe Medical, a pharma-tech company, announced Wednesday that it has obtained Health Canada's approval for its metered-dose medical cannabis inhaler. The inhaler releases predictable, controlled and precise treatment through inhalation, thus providing medical marijuana patients with proper doses of cannabis. "Syqe Medical is proud to bring this first-in-class device, which delivers a specific dose of cannabinoids with each inhalation, helping to relieve symptoms with few, if any, adverse reactions," Perry Davidson, founder and CEO of Syqe Medical, said. The company disclosed that patients ...